Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Nobelpharma |
---|---|
Information provided by: | Nobelpharma |
ClinicalTrials.gov Identifier: | NCT00212355 |
The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Condition | Intervention | Phase |
---|---|---|
Wilson's Disease |
Drug: Wilson's disease |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Phase3,Open-Label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan. |
Ages Eligible for Study: | 1 Year and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | NPC-02-2 |
Study First Received: | September 13, 2005 |
Last Updated: | September 13, 2005 |
ClinicalTrials.gov Identifier: | NCT00212355 History of Changes |
Health Authority: | Japan: Pharmaceuticals and Medical Devices Agency |
Liver Diseases Metabolic Diseases Ganglion Cysts Hepatolenticular Degeneration Basal Ganglia Diseases Central Nervous System Diseases Brain Diseases Neurodegenerative Diseases Metabolism, Inborn Errors |
Digestive System Diseases Heredodegenerative Disorders, Nervous System Genetic Diseases, Inborn Wilson Disease Movement Disorders Zinc Brain Diseases, Metabolic, Inborn Metabolic Disorder Brain Diseases, Metabolic |
Liver Diseases Metabolic Diseases Hepatolenticular Degeneration Basal Ganglia Diseases Nervous System Diseases Central Nervous System Diseases Brain Diseases Neurodegenerative Diseases |
Metal Metabolism, Inborn Errors Metabolism, Inborn Errors Digestive System Diseases Heredodegenerative Disorders, Nervous System Genetic Diseases, Inborn Movement Disorders Brain Diseases, Metabolic, Inborn Brain Diseases, Metabolic |